Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Long-Term Deferred Tax (2018 - 2025)

Historic Long-Term Deferred Tax for Sensus Healthcare (SRTS) over the last 8 years, with Q3 2025 value amounting to $4.2 million.

  • Sensus Healthcare's Long-Term Deferred Tax rose 9285.39% to $4.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year increase of 9285.39%. This contributed to the annual value of $2.2 million for FY2024, which is 619.13% down from last year.
  • As of Q3 2025, Sensus Healthcare's Long-Term Deferred Tax stood at $4.2 million, which was up 9285.39% from $2.8 million recorded in Q2 2025.
  • Over the past 5 years, Sensus Healthcare's Long-Term Deferred Tax peaked at $4.2 million during Q3 2025, and registered a low of $1.3 million during Q1 2024.
  • Its 5-year average for Long-Term Deferred Tax is $2.6 million, with a median of $2.4 million in 2023.
  • Per our database at Business Quant, Sensus Healthcare's Long-Term Deferred Tax crashed by 5507.47% in 2022 and then surged by 9606.74% in 2023.
  • Over the past 5 years, Sensus Healthcare's Long-Term Deferred Tax (Quarter) stood at $3.8 million in 2021, then plummeted by 55.07% to $1.7 million in 2022, then surged by 36.72% to $2.3 million in 2023, then fell by 6.19% to $2.2 million in 2024, then surged by 92.85% to $4.2 million in 2025.
  • Its Long-Term Deferred Tax stands at $4.2 million for Q3 2025, versus $2.8 million for Q2 2025 and $2.1 million for Q1 2025.